These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 7887968

  • 1. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
    Konopka K, Pretzer E, Düzgünes N.
    Biochem Biophys Res Commun; 1995 Mar 08; 208(1):75-81. PubMed ID: 7887968
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R, Decroly E, Kieny MP, Fenouillet E.
    Virology; 2000 Jul 20; 273(1):169-77. PubMed ID: 10891419
    [Abstract] [Full Text] [Related]

  • 6. Anti-HIV activity of multibranched peptide constructs derived either from the cleavage sequence or from the transmembrane domain (gp41) of the human immunodeficiency virus type 1 envelope.
    Sabatier JM, Mabrouk K, Moulard M, Rochat H, Van Rietschoten J, Fenouillet E.
    Virology; 1996 Sep 15; 223(2):406-8. PubMed ID: 8806580
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Coexpression of a nonsyncytium inducer HIV-1 glycoprotein inhibits syncytium formation by another HIV-1 Env protein.
    Li YY, O'Donnell MA, Perez LG.
    Virology; 1996 Jan 15; 215(2):197-202. PubMed ID: 8560767
    [Abstract] [Full Text] [Related]

  • 12. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.
    Zhang X, Gaubin M, Briant L, Srikantan V, Murali R, Saragovi U, Weiner D, Devaux C, Autiero M, Piatier-Tonneau D, Greene MI.
    Nat Biotechnol; 1997 Feb 15; 15(2):150-4. PubMed ID: 9035140
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The HIV-inactivating protein, cyanovirin-N, does not block gp120-mediated virus-to-cell binding.
    Mariner JM, McMahon JB, O'Keefe BR, Nagashima K, Boyd MR.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):841-5. PubMed ID: 9704015
    [Abstract] [Full Text] [Related]

  • 18. Syncytium forming capacity of HIV 1 strains in inhibited by pretreatment of CD4 expressing cells with 3'-azido-3'-deoxythymidine but not by alpha interferon.
    Ruţă SM, Cernescu C.
    Rev Roum Virol; 1994 Jul 30; 45(3-4):171-83. PubMed ID: 7619738
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.